[go: up one dir, main page]

BG105689A - Utilization of pyrimidine derivatives for preventing and treating cerebral ischaemia - Google Patents

Utilization of pyrimidine derivatives for preventing and treating cerebral ischaemia

Info

Publication number
BG105689A
BG105689A BG105689A BG10568901A BG105689A BG 105689 A BG105689 A BG 105689A BG 105689 A BG105689 A BG 105689A BG 10568901 A BG10568901 A BG 10568901A BG 105689 A BG105689 A BG 105689A
Authority
BG
Bulgaria
Prior art keywords
utilization
preventing
pyrimidine derivatives
treating cerebral
cerebral ischaemia
Prior art date
Application number
BG105689A
Other languages
Bulgarian (bg)
English (en)
Inventor
Gerd Steiner
Kurt SCHNELLHAAS
Wilfried Lubisch
Uta Holzenkamp
Dorothea Starck
Monika Knopp
Laszlo Szabo
Franz Emling
Francisco Garcia-Ladona
Hans-Peter Hofmann
Liliane Unger
Original Assignee
Basf Aktiengesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basf Aktiengesellschaft filed Critical Basf Aktiengesellschaft
Publication of BG105689A publication Critical patent/BG105689A/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BG105689A 1999-01-11 2001-07-10 Utilization of pyrimidine derivatives for preventing and treating cerebral ischaemia BG105689A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19900545A DE19900545A1 (de) 1999-01-11 1999-01-11 Verwendung von Pyrimidinderivaten zur Prophylaxe und Therapie der zerebralen Ischämie
PCT/EP1999/010369 WO2000041695A1 (de) 1999-01-11 1999-12-24 Verwendung von pyrimidinderivaten zur prophylaxe und therapie der zerebralen ischämie

Publications (1)

Publication Number Publication Date
BG105689A true BG105689A (en) 2002-02-28

Family

ID=7893836

Family Applications (1)

Application Number Title Priority Date Filing Date
BG105689A BG105689A (en) 1999-01-11 2001-07-10 Utilization of pyrimidine derivatives for preventing and treating cerebral ischaemia

Country Status (24)

Country Link
US (1) US6387912B1 (xx)
EP (1) EP1140096A1 (xx)
JP (1) JP2002534465A (xx)
KR (1) KR20010101442A (xx)
CN (1) CN1334732A (xx)
AU (1) AU2433800A (xx)
BG (1) BG105689A (xx)
BR (1) BR9916887A (xx)
CA (1) CA2359253A1 (xx)
CZ (2) CZ20012484A3 (xx)
DE (1) DE19900545A1 (xx)
HK (1) HK1042649A1 (xx)
HU (1) HUP0201149A3 (xx)
ID (1) ID30022A (xx)
IL (1) IL144146A0 (xx)
MX (1) MXPA01006967A (xx)
MY (1) MY133107A (xx)
NO (1) NO20013409L (xx)
NZ (1) NZ512767A (xx)
PL (1) PL348920A1 (xx)
SK (1) SK9692001A3 (xx)
TR (1) TR200102008T2 (xx)
WO (1) WO2000041695A1 (xx)
ZA (1) ZA200105475B (xx)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19900673A1 (de) 1999-01-11 2000-07-13 Basf Ag Verwendung von Bindungspartnern für 5-HT5-Rezeptoren zur Behandlung neurodegenerativer und neuropsychiatrischer Störungen
US6988199B2 (en) * 2000-07-07 2006-01-17 Message Secure Secure and reliable document delivery
JP4548882B2 (ja) * 1999-11-30 2010-09-22 興和創薬株式会社 4,5,6,7−テトラヒドロチエノ〔2,3−c〕ピリジン化合物
DE10031389A1 (de) * 2000-07-03 2002-01-17 Knoll Ag Pyrimidinderivate und ihre Verwendung zur Prophylaxe und Therapie der zerebralen Ischämie
DE10031390A1 (de) * 2000-07-03 2002-01-17 Knoll Ag Pyrimidinderivate und ihre Verwendung zur Prophylaxe und Therapie der zerebralen Ischämie
DE10259382A1 (de) * 2002-12-18 2004-07-01 Abbott Gmbh & Co. Kg 3-Substituierte 3,4-Dihydro-thieno[2,3-d]pyrimidin-4-on-Derivate, ihre Herstellung und Verwendung
CA2685753A1 (en) * 2007-05-09 2008-11-20 Neuromed Pharmaceuticals Ltd. Bicyclic pyrimidine derivatives as calcium channel blockers
US8927718B2 (en) 2009-08-26 2015-01-06 Takeda Pharmaceutical Company Limited Fused heterocyclic ring derivative and use thereof
WO2021257857A1 (en) 2020-06-19 2021-12-23 Incyte Corporation Naphthyridinone compounds as jak2 v617f inhibitors
US11753413B2 (en) 2020-06-19 2023-09-12 Incyte Corporation Substituted pyrrolo[2,1-f][1,2,4]triazine compounds as JAK2 V617F inhibitors
CA3188639A1 (en) 2020-07-02 2022-01-06 Incyte Corporation Tricyclic urea compounds as jak2 v617f inhibitors
WO2022006456A1 (en) 2020-07-02 2022-01-06 Incyte Corporation Tricyclic pyridone compounds as jak2 v617f inhibitors
WO2022046989A1 (en) 2020-08-27 2022-03-03 Incyte Corporation Tricyclic urea compounds as jak2 v617f inhibitors
US11919908B2 (en) 2020-12-21 2024-03-05 Incyte Corporation Substituted pyrrolo[2,3-d]pyrimidine compounds as JAK2 V617F inhibitors
EP4298099A1 (en) 2021-02-25 2024-01-03 Incyte Corporation Spirocyclic lactams as jak2 v617f inhibitors
JP2025509672A (ja) 2022-03-17 2025-04-11 インサイト・コーポレイション Jak2 v617f阻害剤としての三環式尿素化合物

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4670560A (en) 1986-04-28 1987-06-02 Ortho Pharmaceutical Corporation Thienopyrimidine-2,4-dione derivatives and intermediates thereof
DE19636769A1 (de) 1996-09-10 1998-03-12 Basf Ag 3-Substituierte Pyrido [4',3':4,5]thieno[2,3-d]pyrimidin-Derivate, ihre Herstellung und Verwendung
DE19724980A1 (de) 1997-06-13 1998-12-17 Basf Ag 3-Substituierte 3,4-Dihydro-thieno[2,3-d]pyrimidin-Derivate, ihre Herstellung und Verwendung
DE19724979A1 (de) 1997-06-13 1998-12-17 Basf Ag 3-substituierte Pyrido [3,4,5]thieno[2,3-d]pyrimidin-Derivate, ihre Herstellung und Verwendung

Also Published As

Publication number Publication date
WO2000041695A1 (de) 2000-07-20
TR200102008T2 (tr) 2001-12-21
PL348920A1 (en) 2002-06-17
ID30022A (id) 2001-11-01
NO20013409L (no) 2001-08-30
IL144146A0 (en) 2002-05-23
MXPA01006967A (es) 2002-04-10
DE19900545A1 (de) 2000-07-13
NO20013409D0 (no) 2001-07-10
US6387912B1 (en) 2002-05-14
CA2359253A1 (en) 2000-07-20
EP1140096A1 (de) 2001-10-10
BR9916887A (pt) 2001-11-20
AU2433800A (en) 2000-08-01
HUP0201149A3 (en) 2003-07-28
CZ20012484A3 (cs) 2002-05-15
CZ20012485A3 (cs) 2002-04-17
MY133107A (en) 2007-10-31
HK1042649A1 (zh) 2002-08-23
NZ512767A (en) 2003-05-30
ZA200105475B (en) 2002-10-03
SK9692001A3 (en) 2002-05-09
HUP0201149A2 (hu) 2002-07-29
JP2002534465A (ja) 2002-10-15
KR20010101442A (ko) 2001-11-14
CN1334732A (zh) 2002-02-06

Similar Documents

Publication Publication Date Title
BG105689A (en) Utilization of pyrimidine derivatives for preventing and treating cerebral ischaemia
AP2002002637A0 (en) Novel piperazine
MY140398A (en) 4-AMINO-6-PHENYL-PYRROLO[2,3-d]PYRIMIDINE DERIVATIVES
BG105515A (en) Substituted 2-phenylbenzimidazoles, the production thereof and their use
MY127126A (en) Imidazolo-5-yl-2-anilino-pyrimidines as agents for the inhibition of the cell proliferation
UA74346C2 (uk) Похідні амінодикарбонових кислот, їх застосування та лікарський засіб
MX9700885A (es) Nuevas heteroariloxazolidinonas.
MY133392A (en) Novel substituted pyrazole derivatives
BG105650A (en) Azepinoindole derivatives, the production and use thereof
MX9700886A (es) Nuevas oxazolidinonas sustituidas.
MXPA03010810A (es) Pirimidinas inhibidoras de cdk, su obtencion y su uso como medicamentos.
TWI256951B (en) Thiazolyl amide derivatives
BG108268A (en) Pyrazolopyrimidines as therapeutic agents
GEP20074099B (en) 3-β-D-RIBOFURANO-SYLTHIAZOLO[4,5-d]PYRIDIMINE NUCLEOSIDES AND USES THEREOF
BG106444A (en) Benzodiazepin derivatives, the production and use thereof
HRP20031003A2 (en) 4'-substituted nukleosides
IL158975A0 (en) 2-anilino-pyrimidine derivatives as cyclin dependent kinase inhibitors
PL361355A1 (en) Phenylglycine derivatives
MY130441A (en) Solutions containing epinastin
SE9900961D0 (sv) Novel compounds
SE9802208D0 (sv) Novel compounds
MY133112A (en) 3-amino-3-arylpropan-1-ol derivatives, and their preparation and use
AP2002002697A0 (en) Biciclic cyclohexylamines and their use as NMDA receptor antagonists.
YU30603A (sh) Derivati premošćenog piperazina
SI1268522T1 (sl) Novi antagonisti lhrh, njihova priprava in uporaba kot zdravila